TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full
FORT WORTH, Texas, March 07, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical...
Source: globenewswire.com
Stay updated with breaking news from Gregory Snell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FORT WORTH, Texas, March 07, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical...
Marks the Second Patient to Clinically Benefit from Administration of Voriconazole Inhalation Powder Using Thin Film Freezing-Based Technology Positive Results from First Patient Treated with TFF... | November 1, 2022